Figures 5, 8 present that downregulation of ALKBH5 or p53 significantly decreased Sox2 and increased E-cadherin protein levels, which is consistent with our previous findings and demonstrated the upstream regulating roles of ALKBH5 in modulating malignancies of CSCs derived from NSCLC. This evidence concerns the gene TP53 and non-small cell lung carcinoma.